本页面由Tiger Trade Technology Pte. Ltd.提供服务

Purple Biotech Ltd.

1.31
-0.0200-1.50%
成交量:1.72万
成交额:2.25万
市值:213.12万
市盈率:-0.05
高:1.39
开:1.33
低:1.28
收:1.33
52周最高:14.10
52周最低:1.16
股本:162.69万
流通股本:162.17万
量比:2.20
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-28.8060
每股收益(LYR):-54.9640
净资产收益率:-111.13%
总资产收益率:-20.31%
市净率:0.17
市盈率(LYR):-0.02

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/29

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/03/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/22

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC问询函

Form CORRESP - Correspondence
2023/04/03

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]